Fusion expression of pedA gene to obtain biologically active pediocin PA-1 in Escherichia coli
- 82 Downloads
Two heterologous expression systems using thioredoxin (trxA) as a gene fusion part in Escherichia coli were developed to produce recombinant pediocin PA-1. Pediocin PA-1 structural gene pedA was isolated from Pediococcus acidilactici PA003 by the method of polymerase chain reaction (PCR), then cloned into vector pET32a(+), and expressed as thioredoxin-PedA fusion protein in the host strain E. coli BL21 (DE3). The fusion protein was in the form of inclusion body and was refolded before purification by nickel-iminodiacetic acid (Ni-IDA) agarose resin column. Biological activity of recombinant pediocin PA-1 was analyzed after cleavage of the fusion protein by enterokinase. Agar diffusion test revealed that 512-arbitrary unit (AU) recombinant pediocin PA-1 was obtained from 1 ml culture medium of E. coli (pPA003PED1) using Listeria monocytogenes as the indicator strain. Thioredoxin-PedA fusion gene was further cloned into pET20b(+). Thioredoxin-PedA fusion protein was detected in both the periplasmic and cytoplasmic spaces. The recombinant pediocin PA-1 from the soluble fraction attained 384 AU from 1 ml culture medium of E. coli (pPA003PED2). Therefore, biologically active pediocin PA-1 could be obtained by these two hybrid gene expression methods.
Key wordsBacteriocin Fusion expression Inclusion body Pediocin PA-1 Thioredoxin
Unable to display preview. Download preview PDF.
- Beaulieu, L., Tolkatchev, D., Jetté, J.F., Groleau, D., Subirade, M., 2007. Production of active pediocin PA-1 in Escherichia coli using a thioredoxin gene fusion expression approach: cloning, expression, purification, and characterization. Can. J. Microbiol., 53(11):1246–1258. [doi:10.1139/W07-089]PubMedCrossRefGoogle Scholar
- Kheadr, E., Zihler, A., Dabour, N., Lacroix, C., Blay, G.L., Fliss, I., 2010. Study of the physicochemical and biological stability of pediocin PA-1 in the upper gastrointestinal tract conditions using a dynamic in vitro model. J. Appl. Microbiol., 109(1):54–64. [doi:10.1111/j.1365-2672.2009.04644.x]PubMedGoogle Scholar
- Lee, J.H., Kim, J.H., Hwang, S.W., Lee, W.J., Yoon, H.K., Lee, H.S., Hong, S.S., 2000. High-level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies. Biochem. Biophys. Res. Commun., 277(3):575–580. [doi:10.1006/bbrc.2000.3712]PubMedCrossRefGoogle Scholar
- Sambrook, J., Russell, D.W., 2001. Molecular Cloning: A Laboratory Manual, 3rd Ed. Cold Spring Harbor Laboratory Press, New York, p.1–170.Google Scholar
- Tian, Z.G., Teng, D., Yang, Y.L., Luo, J., Feng, X.J., Fan, Y., Zhang, F., Wang, J.H., 2007. Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4,10 in Escherichia coli. Appl. Microbiol. Biotechnol., 75(1):117–124. [doi:10.1007/s00253-006-0806-7]PubMedCrossRefGoogle Scholar
- Yildirim, S., Konrad, D., Calvez, S., Drider, D., Prevost, H., Lacroix, C., 2007. Production of recombinant bacteriocin divercin V41 by high cell density Escherichia coli batch and fed-batch cultures. Appl. Microbiol. Biotechnol., 77(3):525–531. [doi:10.1007/s00253-007-1188-1]PubMedCrossRefGoogle Scholar
- Zhou, Z.J., Han, Y., Han, X., Zheng, F., 2006. Isolation of bacteriocin-producing Pediococcus acidilactici strain from fermented Chinese cabbage. Food Sci., 27(4):89–92 (in Chinese).Google Scholar